Efficacy and safety of oral iron supplementation with liposomal iron in non-dialysis chronic kidney disease patients with iron deficiency

被引:0
|
作者
Cesarano, Davide [1 ]
Campilongo, Giorgia [2 ]
Papadia, Federica [2 ]
De Marco, Antonia [2 ]
Borrelli, Silvio [1 ]
Cirillo, Pietro [2 ]
Minutolo, Roberto [1 ]
机构
[1] Univ Campania Luigi Vanvitelli, Naples, Italy
[2] Univ Bari Aldo Moro, Bari, Italy
关键词
D O I
暂无
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
2264
引用
收藏
页码:I2325 / I2326
页数:2
相关论文
共 50 条
  • [41] Efficacy and safety of iron supplementation in patients with heart failure and iron deficiency: a meta-analysis
    Zhang, Shuo
    Zhang, Fengxiao
    Du, Meng
    Huang, Kun
    Wang, Cheng
    BRITISH JOURNAL OF NUTRITION, 2019, 121 (08) : 841 - 848
  • [42] A randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatment of iron deficiency anaemia of non-dialysis-dependent chronic kidney disease patients
    Qunibi, Wajeh Y.
    Martinez, Carlos
    Smith, Mark
    Benjamin, Joseph
    Mangione, Antoinette
    Roger, Simon D.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2011, 26 (05) : 1599 - 1607
  • [43] THE RELATIONSHIP BETWEEN HEPCIDIN-25 AND BONE MARROW IRON IN ANEMIC, NON-DIALYSIS, CHRONIC KIDNEY DISEASE PATIENTS
    Capusa, Cristina-Stela
    Mehedinti, Ana-Maria
    Talimba, Gabriela-Adriana
    Stanciu, Ana
    Viasu, Liliana
    Mircescu, Gabriel
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 1193 - 1193
  • [44] CHRONIC KIDNEY DISEASE AND IRON DEFICIENCY
    Hazara, A. M.
    Bhandari, S.
    JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF EDINBURGH, 2014, 44 (02): : 187 - 188
  • [45] Iron sucrose causes greater proteinuria than ferric gluconate in non-dialysis chronic kidney disease
    Agarwal, R.
    Rizkala, A. R.
    Kaskas, M. O.
    Minasian, R.
    Trout, J. R.
    KIDNEY INTERNATIONAL, 2007, 72 (05) : 638 - 642
  • [46] Intravenous iron therapy in non-dialysis CKD patients
    Macdougall, Iain C.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 (04) : 717 - 720
  • [47] Switching Patients with Non-Dialysis Chronic Kidney Disease from Oral Iron to Intravenous Ferric Carboxymaltose: Effects on Erythropoiesis-Stimulating Agent Requirements, Costs, Hemoglobin and Iron Status
    Toblli, Jorge Eduardo
    Di Gennaro, Federico
    PLOS ONE, 2015, 10 (04):
  • [48] Iron sucrose causes greater proteinuria than ferric gluconate in non-dialysis chronic kidney disease
    Jaber, B. L.
    KIDNEY INTERNATIONAL, 2008, 73 (04) : 511 - 512
  • [49] The prevalence of iron deficiency in patients with chronic kidney disease at the time of dialysis initiation.
    Post, JB
    DeVita, MD
    Michelis, MF
    Wilkes, BM
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 464A - 464A
  • [50] Safety of total dose iron dextran infusion in geriatric patients with chronic kidney disease and iron deficiency anemia
    Dossabhoy, Neville R.
    Turley, Steven
    Gascoyne, Rebecca
    Tapolyai, Mihaly
    Sulaiman, Karina
    RENAL FAILURE, 2014, 36 (07) : 1033 - 1037